中汽協:3月汽車銷量按年跌11.7% 新能車銷量增1.1倍
中國汽車工業協會公布月度數據顯示,今年3月汽車產銷數據分別為224.1萬輛和223.4萬輛,按年下滑9.1%和11.7%;按月增長23.4%和28.4%。
今年首季累計,汽車產銷累計648.4萬輛和650.9萬輛,按年增長2%和0.2%。
數據顯示,3月新能源汽車產銷分別完成46.5萬輛和48.4萬輛,按年均增長約1.1倍。
今年首季累計,新能源汽車產銷分別完成129.3萬輛和125.7萬輛,按年均增長約1.4倍。(ta/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.